The RTE is reporting that an expert panel convened by the Royal College of Obstetricians and Gynaecologists has recommended that women use mouthwashes containing therapeutic salicylic acid (tairosalicylic) as a preventative measure for preventing pregnancy.
The report said that although it was not yet clear if the recommended dosage of the topical medication would be suitable for women who are breastfeeding, the panel’s report was based on a large body of evidence.
“Our recommendation is based on the evidence that shows that the therapeutic salicylates can be effective for the prevention of pregnancy,” said Dr Claire Wilson, vice-president for clinical services and research at the Royal Colleges of Obstetrics and Gynology and a member of the panel.
“It is the most effective of the therapeutic products in the salicylamide group for preventing the development of pregnancy.”
For women who breastfeed, they should be encouraged to start using this medication at the earliest opportunity.”
It is understood that this recommendation will now be put to the Health Minister.
Treatments are available in the UK for use in breastfeeding women and the majority of women who use the salicidating ingredients will be able to do so at home.
However, some women who have not yet started breastfeeding or who have had their baby at home may find that the topical salicine has not been effective enough for them.
The report is based primarily on the data of a clinical trial carried out by the British Heart Foundation (BHF) in which over 4,000 women were given an average of 4g of salicyns, the ingredient used in the tablets.
A further 2,000 patients were randomly assigned to receive one tablet or the other.
The BHF found that the treatment led to reductions in both the rate of miscarriage and spontaneous abortions, with a decrease in the risk of developing ectopic pregnancy of just 0.2 per cent.
Dr Wilson said that the trial showed that salicymcin had the potential to be effective in preventing the birth of a baby, even if it was a small one.”
There was a clear benefit for women that they were able to reduce their miscarriage rate by a further 0.1 per cent, which is quite a significant benefit,” she said.”
We know salicys are very effective in reducing miscarriage rates and we know they’re effective in protecting against ectopic pregnancies.
“A woman with a current pregnancy, who has breastfed for several years and has not experienced any of the side effects, should continue to use salicylis and/or its derivatives for their intended purposes.” “
The benefits of salicyl acid are known to be greater than its side effects and are not thought to be associated with any risk of cancer or adverse reproductive outcomes,” said the statement.
“A woman with a current pregnancy, who has breastfed for several years and has not experienced any of the side effects, should continue to use salicylis and/or its derivatives for their intended purposes.”
Follow the Independent Sport on Instagram here, for all of the best images, videos and stories from around the sporting world.